Mariëtte R. Boon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mariëtte R. Boon has a total of 264 co-authors. Here are the top co-authors by number of shared publications:
- Patrick C. N. Rensen
Leiden University Medical Center
13 shared publications Patrick C. N. Rensen
Division of Endocrinology, Department of Medicine Leiden University Medical Center Leiden The Netherlands
12 shared publicationsIngrid M. Jazet
Division of Endocrinology, Department of Medicine Leiden University Medical Center Leiden The Netherlands
10 shared publicationsKimberly J. Nahon
Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
8 shared publications- Elisabeth F. C. van Rossum
Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
6 shared publications - Borja Martinez-Tellez
Department of Medicine, Division of Endocrinology & Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, the Netherlands (S.M.-M., B.M.-T.).
5 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Springer Nature in Metabologia
- Vol. 2 (1) , 18
Subcutaneous adipocyte glucocorticoid-responsive transcripts after modest weight gain in South Asian and White European men: an exploratory longitudinal study
Aims/hypothesis: Adipocyte glucocorticoid (GC)-responsive transcripts are linked to lipid storage and insulin sensitivity, and South Asians develop insulin resistance at lower BMI than White Europeans. We tested whether modest short-term weight gain was associated with adipocyte GC-related transcripts differently by ancestry and whether within-person transcript changes were associated with dynamic insulin responses. Methods: In this exploratory secondary analysis of the GlasVEGAS study, White European ( n = 21) and South Asian ( n = 14) men underwent ~ 6% diet-induced weight gain. Isolated abdominal subcutaneous adipocytes were sampled at baseline and post-weight gain for RT-qPCR assessment of GC-responsive transcripts and related targets. Metabolic responses were characterised using a standardised mixed-meal test with 5 h profiles of glucose, insulin, C-peptide and triglycerides; hepatic triacylglycerol content was quantified by MRI. Results: Weight gain reduced FKBP5 (− 23.65 ± 8.82% in White Europeans; − 17.68 ± 11.62% in South Asians; p = 0.007) and TSC22D3 (also known as GILZ ; − 11.40 ± 2.83%; − 5.95 ± 4.01%; p = 0.001 for change with weight gain), with no ethnicity × intervention interaction ( p ≥ 0.26). HSD11B1 / HSD11B2 and IL2 / IL6 did not change. At baseline, FKBP5 and GILZ were associated with adiposity, liver fat and adipocyte size. Within-person Δ FKBP5 (post-weight gain minus baseline) correlated with Δpostprandial insulin ( r = 0.46, p = 0.006) and ΔC-peptide ( r = 0.34, p = 0.049). Δ GILZ correlated with Δfasting glucose ( r = − 0.40, p = 0.017) and Δpostprandial insulin ( r = 0.34, p = 0.049). In exploratory within-person analyses, changes in FKBP5 and GILZ were associated with changes in postprandial insulin-related measures. Conclusion/interpretation: Early modest weight gain downregulates adipocyte GC-responsive transcripts, with no statistically significant ethnicity-by-weight gain interaction detected in this modest-sized exploratory cohort, and dynamic transcript changes track insulin exposure. These findings implicate a potential link between dynamic insulin responses and adipocyte glucocorticoid-responsive transcription during early weight gain, linking adipocyte transcriptional responses to clinically relevant postprandial insulin physiology.
- 8 October 2026
- Published by Springer Nature in Metabologia
- Vol. 2 (1) , 18
Open AccessSubcutaneous adipocyte glucocorticoid-responsive transcripts after modest weight gain in South Asian and White European men: an exploratory longitudinal study
Aims/hypothesis: Adipocyte glucocorticoid (GC)-responsive transcripts are linked to lipid storage and insulin sensitivity, and South Asians develop insulin resistance at lower BMI than White Europeans. We tested whether modest short-term weight gain was associated with adipocyte GC-related transcripts differently by ancestry and whether within-person transcript changes were associated with dynamic insulin responses. Methods: In this exploratory secondary analysis of the GlasVEGAS study, White European ( n = 21) and South Asian ( n = 14) men underwent ~ 6% diet-induced weight gain. Isolated abdominal subcutaneous adipocytes were sampled at baseline and post-weight gain for RT-qPCR assessment of GC-responsive transcripts and related targets. Metabolic responses were characterised using a standardised mixed-meal test with 5 h profiles of glucose, insulin, C-peptide and triglycerides; hepatic triacylglycerol content was quantified by MRI. Results: Weight gain reduced FKBP5 (− 23.65 ± 8.82% in White Europeans; − 17.68 ± 11.62% in South Asians; p = 0.007) and TSC22D3 (also known as GILZ ; − 11.40 ± 2.83%; − 5.95 ± 4.01%; p = 0.001 for change with weight gain), with no ethnicity × intervention interaction ( p ≥ 0.26). HSD11B1 / HSD11B2 and IL2 / IL6 did not change. At baseline, FKBP5 and GILZ were associated with adiposity, liver fat and adipocyte size. Within-person Δ FKBP5 (post-weight gain minus baseline) correlated with Δpostprandial insulin ( r = 0.46, p = 0.006) and ΔC-peptide ( r = 0.34, p = 0.049). Δ GILZ correlated with Δfasting glucose ( r = − 0.40, p = 0.017) and Δpostprandial insulin ( r = 0.34, p = 0.049). In exploratory within-person analyses, changes in FKBP5 and GILZ were associated with changes in postprandial insulin-related measures. Conclusion/interpretation: Early modest weight gain downregulates adipocyte GC-responsive transcripts, with no statistically significant ethnicity-by-weight gain interaction detected in this modest-sized exploratory cohort, and dynamic transcript changes track insulin exposure. These findings implicate a potential link between dynamic insulin responses and adipocyte glucocorticoid-responsive transcription during early weight gain, linking adipocyte transcriptional responses to clinically relevant postprandial insulin physiology.
- 1 September 2026
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 22 (11) , 627-629
CheckCausesObesity.com: a screening and monitoring tool for obesity
- 1 September 2026
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 22 (11) , 627-629
CheckCausesObesity.com: a screening and monitoring tool for obesity
- Open Access
- 15 April 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (6) , 5078-5090
GLP ‐1, GIP , and Glucagon Excursions During a Mixed Meal Tolerance Test in Young and Lean South Asians Versus Europids
Aims: South Asians exhibit an unfavourable metabolic phenotype characterized by visceral obesity, insulin resistance and dyslipidemia. While various hormones play a critical role in regulating postprandial energy metabolism, it remains unclear whether they respond differently to food intake. We aimed to compare the meal‐induced excursion of incretin hormones (GLP‐1 and GIP) and glucagon between South Asians and Europids. Materials and Methods: Forty nine young, lean South Asian ( n = 24), and Europid ( n = 25) males and females underwent an extended (up to 240 min) mixed meal tolerance test (MMTT). At seven time points circulating incretins (active and total GLP‐1 and GIP), glucagon, and parameters related to glucose (i.e., glucose, insulin) and lipid metabolism were measured. Results: In response to the MMTT, Europids generally exhibited a single peak in glucose levels at t = 30 min, while South Asians tended to display a biphasic glucose response, with peaks at t = 30 and t = 90 min. Among South Asian males, this was accompanied by an increased insulin response, characterized by elevated levels at the corresponding glucose peaks. South Asian females, however, demonstrated a marked drop in circulating glucagon at t = 90 min, and biphasic excursions of total and active GLP‐1 and GIP (t = 30 and t = 120 min). Postprandial lipid excursions did not differ between ethnicities. Conclusions: In contrast to a monophasic glucose response to the MMTT of Europids, South Asians tended to exhibit a biphasic glucose response, with sex‐specific hormonal patterns, suggesting altered incretin and insulin dynamics despite similar postprandial lipid excursions. Trial Registration: ClinicalTrials.gov (NCT05829018; registration date: 25‐04‐2023)
- 15 April 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (6) , 5078-5090
Open AccessGLP ‐1, GIP , and Glucagon Excursions During a Mixed Meal Tolerance Test in Young and Lean South Asians Versus Europids
Aims: South Asians exhibit an unfavourable metabolic phenotype characterized by visceral obesity, insulin resistance and dyslipidemia. While various hormones play a critical role in regulating postprandial energy metabolism, it remains unclear whether they respond differently to food intake. We aimed to compare the meal‐induced excursion of incretin hormones (GLP‐1 and GIP) and glucagon between South Asians and Europids. Materials and Methods: Forty nine young, lean South Asian ( n = 24), and Europid ( n = 25) males and females underwent an extended (up to 240 min) mixed meal tolerance test (MMTT). At seven time points circulating incretins (active and total GLP‐1 and GIP), glucagon, and parameters related to glucose (i.e., glucose, insulin) and lipid metabolism were measured. Results: In response to the MMTT, Europids generally exhibited a single peak in glucose levels at t = 30 min, while South Asians tended to display a biphasic glucose response, with peaks at t = 30 and t = 90 min. Among South Asian males, this was accompanied by an increased insulin response, characterized by elevated levels at the corresponding glucose peaks. South Asian females, however, demonstrated a marked drop in circulating glucagon at t = 90 min, and biphasic excursions of total and active GLP‐1 and GIP (t = 30 and t = 120 min). Postprandial lipid excursions did not differ between ethnicities. Conclusions: In contrast to a monophasic glucose response to the MMTT of Europids, South Asians tended to exhibit a biphasic glucose response, with sex‐specific hormonal patterns, suggesting altered incretin and insulin dynamics despite similar postprandial lipid excursions. Trial Registration: ClinicalTrials.gov (NCT05829018; registration date: 25‐04‐2023)
- Open Access
- 6 January 2026
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 194 (1) , 35-45
Daily hassles and cortisol suppression following low-dose dexamethasone suppression test are independently associated with cardiovascular disease
Objective: Chronic stress is linked to cardiometabolic diseases through increased glucocorticoid exposure, but the impact of daily life stress on glucocorticoid regulation and cardiometabolic health remains underexplored. This study investigated these associations. Design: This is a cross-sectional analysis of participants from the Netherlands Study of Depression and Anxiety (NESDA) without psychiatric diagnosis in the prior 6 months. Methods: We included 870 participants (64.7% female, median age 47.0 years). Daily life stress was assessed using the Daily Hassles Questionnaire (DHQ). Salivary cortisol was analyzed for 1-h awakening cortisol (4 time points), evening cortisol, and slope. Also an overnight 0.5 mg dexamethasone suppression test was performed. Associations between DHQ, glucocorticoid measures, and cardiometabolic health were studied using logistic and linear regressions. Results: After multivariable adjustment, each standard deviation (SD) increase in DHQ score was associated with 1.38 times (95% confidence interval [CI] 1.07; 1.77) higher odds of cardiovascular disease (CVD), but not diabetes, metabolic syndrome, or obesity. Higher DHQ scores were also associated with higher evening cortisol levels. In addition, each SD increase in cortisol suppression ratio was associated with 1.36 times (95% CI 1.08; 1.72) higher odds of CVD, but not diabetes, metabolic syndrome, or obesity. No interactions between DHQ and glucocorticoid measures on CVD were observed. Conclusion: A higher cortisol suppression ratio, indicative of increased glucocorticoid sensitivity, and increased daily hassles were both independently associated with having CVD. The absence of interaction suggests they influence CVD through separate pathways, highlighting the need for further research to better understand stress mechanisms and identify “stress profiles” most closely linked to cardiometabolic diseases.
- 6 January 2026
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 194 (1) , 35-45
Open AccessDaily hassles and cortisol suppression following low-dose dexamethasone suppression test are independently associated with cardiovascular disease
Objective: Chronic stress is linked to cardiometabolic diseases through increased glucocorticoid exposure, but the impact of daily life stress on glucocorticoid regulation and cardiometabolic health remains underexplored. This study investigated these associations. Design: This is a cross-sectional analysis of participants from the Netherlands Study of Depression and Anxiety (NESDA) without psychiatric diagnosis in the prior 6 months. Methods: We included 870 participants (64.7% female, median age 47.0 years). Daily life stress was assessed using the Daily Hassles Questionnaire (DHQ). Salivary cortisol was analyzed for 1-h awakening cortisol (4 time points), evening cortisol, and slope. Also an overnight 0.5 mg dexamethasone suppression test was performed. Associations between DHQ, glucocorticoid measures, and cardiometabolic health were studied using logistic and linear regressions. Results: After multivariable adjustment, each standard deviation (SD) increase in DHQ score was associated with 1.38 times (95% confidence interval [CI] 1.07; 1.77) higher odds of cardiovascular disease (CVD), but not diabetes, metabolic syndrome, or obesity. Higher DHQ scores were also associated with higher evening cortisol levels. In addition, each SD increase in cortisol suppression ratio was associated with 1.36 times (95% CI 1.08; 1.72) higher odds of CVD, but not diabetes, metabolic syndrome, or obesity. No interactions between DHQ and glucocorticoid measures on CVD were observed. Conclusion: A higher cortisol suppression ratio, indicative of increased glucocorticoid sensitivity, and increased daily hassles were both independently associated with having CVD. The absence of interaction suggests they influence CVD through separate pathways, highlighting the need for further research to better understand stress mechanisms and identify “stress profiles” most closely linked to cardiometabolic diseases.
- Open Access
- 5 January 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (3) , 2095-2104
Mental health changes after 4 months of weight loss treatment with the glucagon‐like peptide‐1 analogue liraglutide 3.0 mg
Objective: This observational study examined changes in mental health and wellbeing after 4‐months liraglutide 3.0 mg treatment in patients with obesity and explored associations with weight loss. Methods: We included 98 patients with obesity treated with liraglutide 3.0 mg. The Hospital Anxiety and Depression Scale (HADS: total score 0–42; depression/anxiety subscales 0–21), OBESI‐Q psychological wellbeing (0–100) and anthropometrics were assessed at baseline and 4‐month follow‐up. Analyses included the full sample and subgroups with poor versus good baseline mental health. Results: Body weight decreased after 4 months (−5.8%, p < 0.001). HADS total, depression, and (in trend) anxiety scores slightly decreased (−1.7 [95% confidence interval [CI] −3.2; −0.1, p < 0.05]; −1.0 [95% CI: −1.9; −0.1, p < 0.05] and −0.7 [95% CI: −1.5; 0.1, p = 0.095]). OBESI‐Q psychological wellbeing scores increased (4.3 [95% CI: 0.8; 7.8, p < 0.05]). Mental health improvements occurred mainly in patients with poor baseline mental health. Weight loss occurred regardless of initial mental health. Anthropometrics changes were associated with changes in mental health and psychological wellbeing either significantly or in trend. Conclusion: Liraglutide treatment was associated with weight loss without adverse mental health changes. Mental health benefits may be seen especially in those initially impaired. Weight loss was irrespective of baseline mental health status, suggesting liraglutide weight loss treatment effectiveness even in the presence of impaired mental health.
- 5 January 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (3) , 2095-2104
Open AccessMental health changes after 4 months of weight loss treatment with the glucagon‐like peptide‐1 analogue liraglutide 3.0 mg
Objective: This observational study examined changes in mental health and wellbeing after 4‐months liraglutide 3.0 mg treatment in patients with obesity and explored associations with weight loss. Methods: We included 98 patients with obesity treated with liraglutide 3.0 mg. The Hospital Anxiety and Depression Scale (HADS: total score 0–42; depression/anxiety subscales 0–21), OBESI‐Q psychological wellbeing (0–100) and anthropometrics were assessed at baseline and 4‐month follow‐up. Analyses included the full sample and subgroups with poor versus good baseline mental health. Results: Body weight decreased after 4 months (−5.8%, p < 0.001). HADS total, depression, and (in trend) anxiety scores slightly decreased (−1.7 [95% confidence interval [CI] −3.2; −0.1, p < 0.05]; −1.0 [95% CI: −1.9; −0.1, p < 0.05] and −0.7 [95% CI: −1.5; 0.1, p = 0.095]). OBESI‐Q psychological wellbeing scores increased (4.3 [95% CI: 0.8; 7.8, p < 0.05]). Mental health improvements occurred mainly in patients with poor baseline mental health. Weight loss occurred regardless of initial mental health. Anthropometrics changes were associated with changes in mental health and psychological wellbeing either significantly or in trend. Conclusion: Liraglutide treatment was associated with weight loss without adverse mental health changes. Mental health benefits may be seen especially in those initially impaired. Weight loss was irrespective of baseline mental health status, suggesting liraglutide weight loss treatment effectiveness even in the presence of impaired mental health.
- Open Access
- 4 September 2025
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 2 (4)
Lifestyle Recommendations in the Dutch Clinical Practice Guidelines
Introduction: Medical specialists play an essential role in guiding lifestyle changes in chronically ill patients, contributing to health‐related prevention. Clinical practice guidelines (CPGs) are an important tool to support medical specialists to implement health‐related prevention in daily practice. However, it remains unclear how recommendations on lifestyle interventions are part of CPGs. Therefore, the objective of this study was to analyse existing lifestyle recommendations in Dutch CPGs for medical specialists. Methods: Using a mixed‐methods approach, the study examined 130 CPGs to assess the prevalence, type of lifestyle factors being addressed, level of evidence according to GRADE, knowledge gaps and wording of lifestyle recommendations. Results: Results indicated that 65% of the examined CPGs included lifestyle recommendations, with increasing physical activity and improving nutrition being the most addressed factors. Despite only 11% of the recommendations being supported by moderate to high certainty of evidence, 62% were strongly formulated. At the same time, the analysis also revealed unclarity in the wording of recommendations regarding who, what and when to act. Finally, this study shows notable knowledge gaps regarding the effectiveness and feasibility of lifestyle interventions in daily practice. Discussion: Despite robust evidence, lifestyle recommendations do have a prominent position in CPGs for chronic diseases in specialist' care. Further research is needed to answer to the knowledge gaps and to what is needed for lifestyle recommendations to be implemented in daily practice.
- 4 September 2025
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 2 (4)
Open AccessLifestyle Recommendations in the Dutch Clinical Practice Guidelines
Introduction: Medical specialists play an essential role in guiding lifestyle changes in chronically ill patients, contributing to health‐related prevention. Clinical practice guidelines (CPGs) are an important tool to support medical specialists to implement health‐related prevention in daily practice. However, it remains unclear how recommendations on lifestyle interventions are part of CPGs. Therefore, the objective of this study was to analyse existing lifestyle recommendations in Dutch CPGs for medical specialists. Methods: Using a mixed‐methods approach, the study examined 130 CPGs to assess the prevalence, type of lifestyle factors being addressed, level of evidence according to GRADE, knowledge gaps and wording of lifestyle recommendations. Results: Results indicated that 65% of the examined CPGs included lifestyle recommendations, with increasing physical activity and improving nutrition being the most addressed factors. Despite only 11% of the recommendations being supported by moderate to high certainty of evidence, 62% were strongly formulated. At the same time, the analysis also revealed unclarity in the wording of recommendations regarding who, what and when to act. Finally, this study shows notable knowledge gaps regarding the effectiveness and feasibility of lifestyle interventions in daily practice. Discussion: Despite robust evidence, lifestyle recommendations do have a prominent position in CPGs for chronic diseases in specialist' care. Further research is needed to answer to the knowledge gaps and to what is needed for lifestyle recommendations to be implemented in daily practice.
- Open Access
- 11 January 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (1) , e70307
Cold exposure and thermoneutrality similarly reduce supraclavicular brown adipose tissue fat fraction in fasted young lean adults
Brown adipose tissue (BAT) is a metabolically highly active tissue that dissipates energy stored within its intracellular triglyceride droplets as heat. Others have previously utilized MRI to show that the fat fraction of human supraclavicular BAT (scBAT) decreases upon cold exposure, compared with baseline (i.e., pre‐cooling). However, comparisons to a control group that was not exposed to cold are largely lacking. We recently developed a non‐invasive dynamic MRI protocol that allows for quantifying scBAT fat fraction changes over time. Here, we aimed to study the effect of cold exposure versus thermoneutrality on fat fraction changes in human scBAT. Ten young (mean age: 21.5 ± 0.7 years), lean (mean BMI: 21.7 ± 0.5 kg/m 2 ), 12 h‐fasted volunteers (9 females; 1 male) underwent up to 70 consecutive MRI scans each on two separate study visits in a cross‐over design. Participants were exposed to a temperature of 32°C for 10 scans (i.e., ±16 min), which was then either lowered to 18°C (i.e., cold exposure) or was maintained at 32°C (i.e., thermoneutrality). Dynamic fat fraction changes were quantified, and self‐reported thermal perception scores were monitored. The fat fraction in scBAT decreased over time upon cold exposure ( r = −.222, p < .001). Interestingly however, we also observed a decrease in scBAT fat fraction over time upon thermoneutrality ( r = −.212, p < .001). No difference was observed between the two temperature conditions ( p = .55), while self‐reported thermal perception scores were consistently higher (i.e., colder) upon cold exposure. In the trapezius muscle and the humerus bone as control tissues, the fat fraction was unaffected in both temperature conditions. The fat fraction in subcutaneous white adipose tissue (sWAT) however, also decreased over time upon cold exposure ( r = −.270, p < .001) and during thermoneutrality ( r = −.190, p < .001), again with no difference ( p = .92) between the two temperature conditions. In conclusion, our results show that in 12 h‐fasted, healthy individuals cold exposure and thermoneutrality similarly reduce the fat fraction within scBAT and sWAT. While we interpret that the cold exposure was sufficient to induce thermogenesis, we suggest that an increased lipolytic activity within adipocytes, as a consequence of fasting, may be the primary cause of the decreased fat fraction in both sWAT and scBAT in our study. The current study highlights the potential influence of fasting on the fat fraction in scBAT and stresses the importance of inclusion of a thermoneutral control group in studies investigating the BAT‐modulating effect of cold exposure.
- 11 January 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (1) , e70307
Open AccessCold exposure and thermoneutrality similarly reduce supraclavicular brown adipose tissue fat fraction in fasted young lean adults
Brown adipose tissue (BAT) is a metabolically highly active tissue that dissipates energy stored within its intracellular triglyceride droplets as heat. Others have previously utilized MRI to show that the fat fraction of human supraclavicular BAT (scBAT) decreases upon cold exposure, compared with baseline (i.e., pre‐cooling). However, comparisons to a control group that was not exposed to cold are largely lacking. We recently developed a non‐invasive dynamic MRI protocol that allows for quantifying scBAT fat fraction changes over time. Here, we aimed to study the effect of cold exposure versus thermoneutrality on fat fraction changes in human scBAT. Ten young (mean age: 21.5 ± 0.7 years), lean (mean BMI: 21.7 ± 0.5 kg/m 2 ), 12 h‐fasted volunteers (9 females; 1 male) underwent up to 70 consecutive MRI scans each on two separate study visits in a cross‐over design. Participants were exposed to a temperature of 32°C for 10 scans (i.e., ±16 min), which was then either lowered to 18°C (i.e., cold exposure) or was maintained at 32°C (i.e., thermoneutrality). Dynamic fat fraction changes were quantified, and self‐reported thermal perception scores were monitored. The fat fraction in scBAT decreased over time upon cold exposure ( r = −.222, p < .001). Interestingly however, we also observed a decrease in scBAT fat fraction over time upon thermoneutrality ( r = −.212, p < .001). No difference was observed between the two temperature conditions ( p = .55), while self‐reported thermal perception scores were consistently higher (i.e., colder) upon cold exposure. In the trapezius muscle and the humerus bone as control tissues, the fat fraction was unaffected in both temperature conditions. The fat fraction in subcutaneous white adipose tissue (sWAT) however, also decreased over time upon cold exposure ( r = −.270, p < .001) and during thermoneutrality ( r = −.190, p < .001), again with no difference ( p = .92) between the two temperature conditions. In conclusion, our results show that in 12 h‐fasted, healthy individuals cold exposure and thermoneutrality similarly reduce the fat fraction within scBAT and sWAT. While we interpret that the cold exposure was sufficient to induce thermogenesis, we suggest that an increased lipolytic activity within adipocytes, as a consequence of fasting, may be the primary cause of the decreased fat fraction in both sWAT and scBAT in our study. The current study highlights the potential influence of fasting on the fat fraction in scBAT and stresses the importance of inclusion of a thermoneutral control group in studies investigating the BAT‐modulating effect of cold exposure.
- Top Cited PapersOpen Access
- 2 December 2024
- Published by Wiley in Clinical Obesity
- Vol. 15 (2) , e12725
Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions
Summary: Chronic stress, characterized by increased long‐term exposure to the glucocorticoid hormone cortisol, is increasingly linked to obesity development. Still, various knowledge gaps persist, including on underlying pathophysiological mechanisms. The aim of the current review is to provide the latest insights on the connection between stress and obesity. We discuss three biological stress systems—the autonomic nervous system, the hypothalamus–pituitary–adrenal (HPA) axis and the immune system—and their link with obesity, with a particular focus on the HPA axis. The role of cortisol and its regulatory variations (including glucocorticoid rhythmicity and altered sensitivity) in adipose tissue biology and obesity development is discussed. Moreover, we highlight the physiological, affective, cognitive and behavioural dimensions of the stress response offering a deeper understanding of how stress contributes to obesity development and vice versa. Finally, stress as a treatment target for obesity is discussed. We conclude that the link between stress and obesity is complex and multifaceted, influenced by physiological, affective, cognitive and behavioural stress response mechanisms, which especially when chronically present, play a key role in the development of obesity and associated cardiometabolic diseases. This necessitates integrated approaches tailored to individual needs, including lifestyle modifications, behavioural interventions, psychosocial support and possible additional pharmacological interventions.
- 2 December 2024
- Published by Wiley in Clinical Obesity
- Vol. 15 (2) , e12725
Top Cited PapersOpen AccessGlucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions
Summary: Chronic stress, characterized by increased long‐term exposure to the glucocorticoid hormone cortisol, is increasingly linked to obesity development. Still, various knowledge gaps persist, including on underlying pathophysiological mechanisms. The aim of the current review is to provide the latest insights on the connection between stress and obesity. We discuss three biological stress systems—the autonomic nervous system, the hypothalamus–pituitary–adrenal (HPA) axis and the immune system—and their link with obesity, with a particular focus on the HPA axis. The role of cortisol and its regulatory variations (including glucocorticoid rhythmicity and altered sensitivity) in adipose tissue biology and obesity development is discussed. Moreover, we highlight the physiological, affective, cognitive and behavioural dimensions of the stress response offering a deeper understanding of how stress contributes to obesity development and vice versa. Finally, stress as a treatment target for obesity is discussed. We conclude that the link between stress and obesity is complex and multifaceted, influenced by physiological, affective, cognitive and behavioural stress response mechanisms, which especially when chronically present, play a key role in the development of obesity and associated cardiometabolic diseases. This necessitates integrated approaches tailored to individual needs, including lifestyle modifications, behavioural interventions, psychosocial support and possible additional pharmacological interventions.
- Open Access
Clinical phenotypes of adults with monogenic and syndromic genetic obesity
Objective: Considering limited evidence on diagnostics of genetic obesity in adults, we evaluated phenotypes of adults with genetic obesity. Additionally, we assessed the applicability of Endocrine Society (ES) recommendations for genetic testing in pediatric obesity.Methods: We compared clinical features, including age of onset of obesity and appetite, between adults with non‐syndromic monogenic obesity (MO), adults with syndromic obesity (SO), and adults with common obesity (CO) as control patients.Results: A total of 79 adults with genetic obesity (32 with MO, 47 with SO) were compared with 186 control patients with CO. Median BMI was similar among the groups: 41.2, 39.5, and 38.7 kg/m2 for patients with MO, SO, and CO, respectively. Median age of onset of obesity was 3 (IQR: 1–6) years in patients with MO, 9 (IQR: 4–13) years in patients with SO, and 21 (IQR: 13–33) years in patients with CO (p < 0.001). Patients with genetic obesity more often reported increased appetite: 65.6%, 68.1%, and 33.9% in patients with MO, SO, and CO, respectively (p < 0.001). Intellectual deficit and autism spectrum disorder were more prevalent in patients with SO (53.2% and 21.3%) compared with those with MO (3.1% and 6.3%) and CO (both 0.0%). The ES recommendations were fulfilled in 56.3%, 29.8%, and 2.7% of patients with MO, SO, and CO, respectively (p < 0.001).Conclusions: We found distinct phenotypes in adult genetic obesity. Additionally, we demonstrated low sensitivity for detecting genetic obesity in adults using pediatric ES recommendations, necessitating specific genetic testing recommendations in adult obesity care.
Open AccessClinical phenotypes of adults with monogenic and syndromic genetic obesity
Objective: Considering limited evidence on diagnostics of genetic obesity in adults, we evaluated phenotypes of adults with genetic obesity. Additionally, we assessed the applicability of Endocrine Society (ES) recommendations for genetic testing in pediatric obesity.Methods: We compared clinical features, including age of onset of obesity and appetite, between adults with non‐syndromic monogenic obesity (MO), adults with syndromic obesity (SO), and adults with common obesity (CO) as control patients.Results: A total of 79 adults with genetic obesity (32 with MO, 47 with SO) were compared with 186 control patients with CO. Median BMI was similar among the groups: 41.2, 39.5, and 38.7 kg/m2 for patients with MO, SO, and CO, respectively. Median age of onset of obesity was 3 (IQR: 1–6) years in patients with MO, 9 (IQR: 4–13) years in patients with SO, and 21 (IQR: 13–33) years in patients with CO (p < 0.001). Patients with genetic obesity more often reported increased appetite: 65.6%, 68.1%, and 33.9% in patients with MO, SO, and CO, respectively (p < 0.001). Intellectual deficit and autism spectrum disorder were more prevalent in patients with SO (53.2% and 21.3%) compared with those with MO (3.1% and 6.3%) and CO (both 0.0%). The ES recommendations were fulfilled in 56.3%, 29.8%, and 2.7% of patients with MO, SO, and CO, respectively (p < 0.001).Conclusions: We found distinct phenotypes in adult genetic obesity. Additionally, we demonstrated low sensitivity for detecting genetic obesity in adults using pediatric ES recommendations, necessitating specific genetic testing recommendations in adult obesity care.
- Open Access
- 15 May 2023
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 90 (4) , 1316-1327
Image registration and mutual thresholding enable low interimage variability across dynamic MRI measurements of supraclavicular brown adipose tissue during mild cold exposure
Purpose: Activated brown adipose tissue (BAT) enhances lipid catabolism and improves cardiometabolic health. Quantitative MRI of the fat fraction (FF) of supraclavicular BAT (scBAT) is a promising noninvasive measure to assess BAT activity but suffers from high scan variability. We aimed to test the effects of coregistration and mutual thresholding on the scan variability in a fast (1 min) time‐resolution MRI protocol for assessing scBAT FF changes during cold exposure.Methods: Ten volunteers (age 24.8 ± 3.0 years; body mass index 21.2 ± 2.1 kg/m2) were scanned during thermoneutrality (32°C; 10 min) and mild cold exposure (18°C; 60 min) using a 12‐point gradient‐echo sequence (70 consecutive scans with breath‐holds, 1.03 min per dynamic).Dynamics were coregistered to the first thermoneutral scan, which enabled drawing of single regions of interest in the scBAT depot. Voxel‐wise FF changes were calculated at each time point and averaged across regions of interest. We applied mutual FF thresholding, in which voxels were included if their FF was greater than 30% FF in the reference scan and the registered dynamic. The efficacy of the coregistration was determined by using a moving average and comparing the mean squared error of residuals between registered and nonregistered data. Registered scBAT ΔFF was compared with single‐scan thresholding using the moving average method.Results: Registered scBAT ΔFF had lower mean square error values than nonregistered data (0.07 ± 0.05% vs. 0.16 ± 0.14%; p < 0.05), and mutual thresholding reduced the scBAT ΔFF variability by 30%.Conclusion: We demonstrate that coregistration and mutual thresholding improve stability of the data 2‐fold, enabling assessment of small changes in FF following cold exposure.
- 15 May 2023
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 90 (4) , 1316-1327
Open AccessImage registration and mutual thresholding enable low interimage variability across dynamic MRI measurements of supraclavicular brown adipose tissue during mild cold exposure
Purpose: Activated brown adipose tissue (BAT) enhances lipid catabolism and improves cardiometabolic health. Quantitative MRI of the fat fraction (FF) of supraclavicular BAT (scBAT) is a promising noninvasive measure to assess BAT activity but suffers from high scan variability. We aimed to test the effects of coregistration and mutual thresholding on the scan variability in a fast (1 min) time‐resolution MRI protocol for assessing scBAT FF changes during cold exposure.Methods: Ten volunteers (age 24.8 ± 3.0 years; body mass index 21.2 ± 2.1 kg/m2) were scanned during thermoneutrality (32°C; 10 min) and mild cold exposure (18°C; 60 min) using a 12‐point gradient‐echo sequence (70 consecutive scans with breath‐holds, 1.03 min per dynamic).Dynamics were coregistered to the first thermoneutral scan, which enabled drawing of single regions of interest in the scBAT depot. Voxel‐wise FF changes were calculated at each time point and averaged across regions of interest. We applied mutual FF thresholding, in which voxels were included if their FF was greater than 30% FF in the reference scan and the registered dynamic. The efficacy of the coregistration was determined by using a moving average and comparing the mean squared error of residuals between registered and nonregistered data. Registered scBAT ΔFF was compared with single‐scan thresholding using the moving average method.Results: Registered scBAT ΔFF had lower mean square error values than nonregistered data (0.07 ± 0.05% vs. 0.16 ± 0.14%; p < 0.05), and mutual thresholding reduced the scBAT ΔFF variability by 30%.Conclusion: We demonstrate that coregistration and mutual thresholding improve stability of the data 2‐fold, enabling assessment of small changes in FF following cold exposure.